Neurodegenerative disease and brain delivery of therapeutics: Bridging the gap using dendrimers
Neurodegenerative diseases (NDs) continue to burden human lives and economic
conditions. They continue to challenge the healthcare system due to the associated …
conditions. They continue to challenge the healthcare system due to the associated …
Cell membrane-based nanomaterials for theranostics of central nervous system diseases
W Li, J Cheng, F He, P Zhang, N Zhang, J Wang… - Journal of …, 2023 - Springer
Central nervous system (CNS) diseases have been widely acknowledged as one of the
major healthy concerns globally, which lead to serious impacts on human health. There will …
major healthy concerns globally, which lead to serious impacts on human health. There will …
[HTML][HTML] Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression
Alzheimer's disease (AD) is a type of dementia that affects a vast number of people around
the world, causing a great deal of misery and death. Evidence reveals a relationship …
the world, causing a great deal of misery and death. Evidence reveals a relationship …
[图书][B] CPP, cell-penetrating peptides
Ü Langel - 2019 - Springer
The genesis of cell-penetrating peptide research (CPP; also known as prote/peptide
transduction domains, PTD, or Trojan peptides) was born from the publication of two parallel …
transduction domains, PTD, or Trojan peptides) was born from the publication of two parallel …
[HTML][HTML] Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease
Alzheimer's disease (AD) is a very common neurodegenerative disorder associated with
memory loss and a progressive decline in cognitive activity. The two major …
memory loss and a progressive decline in cognitive activity. The two major …
[HTML][HTML] Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer's disease
J Wang, Z Wang, Y Li, Y Hou, C Yin, E Yang, Z Liao… - Biomaterials, 2023 - Elsevier
Alzheimer's disease (AD) as a common neurodegenerative disease showed progressive
cognitive dysfunction and behavioral impairment. Currently, the deposition of amyloid β …
cognitive dysfunction and behavioral impairment. Currently, the deposition of amyloid β …
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
The prevalence of neurodegenerative disorders (NDs) has increased recently, with
Parkinson's disease (PD) and Alzheimer's disease (AD) being the two utmost prevalent …
Parkinson's disease (PD) and Alzheimer's disease (AD) being the two utmost prevalent …
Drug delivery for brains and central nervous system
A Serajian, M Hassanpour, G Heidari - Materials Chemistry Horizons, 2023 - mch.du.ac.ir
This comprehensive review delves into the intricate challenges and recent advancements in
drug delivery to the central nervous system (CNS), with a primary focus on overcoming the …
drug delivery to the central nervous system (CNS), with a primary focus on overcoming the …
Targeting reactive astrocytes by pH-responsive ligand-bonded polymeric nanoparticles in spinal cord injury
In spinal cord injuries, axonal regeneration decreases with the activation of astrocytes
followed by glial scar formation. Targeting reactive astrocytes has been recently performed …
followed by glial scar formation. Targeting reactive astrocytes has been recently performed …
Development and evaluation of multi‐functionalized sialic acid conjugated asiatic acid nanoconstruct to mitigate cognitive deficits in Alzheimer's disease
Sialic acid (SA) serves a critical role in neuronal repair and cognitive functions. SA is a nine‐
carbon carboxylated sugar with a glycoconjugate cap that acts as a ligand and surface …
carbon carboxylated sugar with a glycoconjugate cap that acts as a ligand and surface …